Felipe S.
- Country
- France
- Department
- Hématologie Adultes
Research Overview
- Randomized Precision Medicine Trial of Venetoclax Combination Therapy in Relapsed/Refractory T‑Cell Acute Lymphoblastic Leukemia
- Phase I/II Open‑Label Study Assessing Safety and Efficacy of LV‑FOXP3‑T4 Induced CD4⁺ Treg Cell Therapy ± Low‑Dose Aldesleukin in Patients with IPEX Syndrome
- Phase 3 Study of Idarubicin, Daunorubicin, Cytarabine, and Mycophenolic Acid in Acute Myeloid Leukemia Patients Aged 18-60
Data & Insights
Has run more than one trial at 62 of 157 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating various blood cancers, with particular focus on acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) in adult patients. Their expertise extends to myelodysplastic syndrome, especially cases involving IDH1 mutations.
- Adult ALL Treatment Protocols
- AML Management Strategies
- Myelodysplastic Disorders
Transplant Medicine
The investigator has significant expertise in allogeneic stem cell transplantation and related complications. Their work encompasses graft versus host disease management and innovative approaches to donor lymphocyte infusions.
- Haploidentical Transplantation
- Post-Transplant Complications
- Pure Red Cell Aplasia Management
Rare Disorders
The investigator focuses on treating rare conditions including Epstein-Barr virus associated diseases, chronic neutropenic disorders, and myelofibrosis. Their work includes managing progressive multifocal leukoencephalopathy in immunocompromised patients.
- EBV-Related Disorders
- Neutropenia Management
- Myeloproliferative Conditions
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.